---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-005029"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-02-06T23:59:59+00:00"
generated_at: "2026-06-06T08:05:46.127409+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Processa regains Nasdaq minimum bid price compliance; delisting risk resolved

## Summary
- Received written notice from Nasdaq on Feb 6, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Achieved minimum $1.00 closing bid price for 10 consecutive business days ending Feb 2, 2024.
- Matter is now closed; no further deficiency or delisting action pending.
- Stock ticker PCSA; compliance removal removes immediate delisting overhang.

## SEC filing metadata
- accession: 0001493152-24-005029
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-02-06T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/0001493152-24-005029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-005029
- JSON: https://secwatch.observer/filing/0001493152-24-005029.json
- Plain text: https://secwatch.observer/filing/0001493152-24-005029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.